Aardvark Therapeutics, Inc. (AARD)
NASDAQ · Healthcare
Aardvark Therapeutics, Inc. Cash on Hand 2024–2025
Aardvark Therapeutics, Inc. annual/quarterly cash on hand history from 2024 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Aardvark Therapeutics, Inc. cash on hand for the quarter ending December 31, 2025 were 47.1M, a 23.67% decrease year-over-year.
- Aardvark Therapeutics, Inc. cash on hand for 2025 were 47.1M, a 23.67% decrease from 2024.
- Aardvark Therapeutics, Inc. cash on hand for 2024 were 61.6M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aardvark Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $47 |
| 2024 | $62 |
| Aardvark Therapeutics, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $47 |
| 2024-12-31 | $62 |
Aardvark Therapeutics, Inc. Cash on Hand — FAQ
Aardvark Therapeutics, Inc. (AARD) cash on hand over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AARD's cash on hand history?
The chart and table above show Aardvark Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.